EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses

Jacopo Canzian iD, Fabio Conforti, Flavia Jacobs iD, Chiara Benvenuti iD, Mariangela Gaudio iD, Riccardo Gerosa iD, Rita De Sanctis iD, Alberto Zambelli

Cancers · 21.03.2025 · 17 (7) · 1054

DOI: 10.3390/cancers17071054 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.03.2025. Verfasst von Jacopo Canzian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significant sex-based differences exist in the immune system and antitumor immune responses, potentially leading to variations in both the efficacy and toxicity of anticancer immunotherapies. Women generally mount stronger innate and adaptive immune responses than men, which can result in more severe immune-related adverse events (irAEs) during treatments with immune checkpoint inhibitors (ICIs). However, the importance of sex dimorphism in the safety of cancer immunotherapy remains underexplored in clinical oncology, despite its profound implications for treatment outcomes. Our review highlights the critical influence of biological sex on pharmacokinetics, pharmacodynamics, and immune responses, shaping ICI efficacy and the prevalence, type, and severity of irAEs. Integrating sex as a critical variable in cancer treatment and clinical trial design is essential for personalizing therapeutic strategies, bridging existing knowledge gaps, and enhancing survival rates and quality of life for patients across genders.

Schlagwörter

Stichwörter der Autor:innen

immune checkpoint inhibitorsimmune-related adverse eventssex dimorphism

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
  • Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
  • Division of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
  • Oncology Unit, ASST Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.
  • Department of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.

ORCID-Profile: Jacopo Canzian, Flavia Jacobs, Chiara Benvenuti, Mariangela Gaudio, Riccardo Gerosa, Rita De Sanctis

Zitieren

APA

Canzian, J., Conforti, F., Jacobs, F., Benvenuti, C., Gaudio, M., Gerosa, R., De Sanctis, R., & Zambelli, A. (2025). Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses. Cancers, 17(7), 1054. https://doi.org/10.3390/cancers17071054

Vancouver

Canzian J, Conforti F, Jacobs F, Benvenuti C, Gaudio M, Gerosa R, et al. Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses. Cancers. 2025;17(7):1054. doi:10.3390/cancers17071054

BibTeX
@article{Canzian2025,
  author = {Canzian, Jacopo and Conforti, Fabio and Jacobs, Flavia and Benvenuti, Chiara and Gaudio, Mariangela and Gerosa, Riccardo and De Sanctis, Rita and Zambelli, Alberto},
  title = {Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1054},
  doi = {10.3390/cancers17071054}
}
Kostenlos starten →